Through ex vivo flow cytometric data obtained prior to clinical interventions of all the patients in the cohort, we have also investigated if the CD8+/CD4+ TIL ratio is a risk factor for cervical cancer. This evidence concerns the gene CD4 and cervical carcinoma.